Filter Results:
(264)
Show Results For
- All HBS Web
(264)
- News (128)
- Research (118)
- Events (3)
- Multimedia (3)
- Faculty Publications (62)
Show Results For
- All HBS Web
(264)
- News (128)
- Research (118)
- Events (3)
- Multimedia (3)
- Faculty Publications (62)
- Article
From Blood Diamonds to Dirty Gold: How to Buy Gold Less Tainted by Mercury
By: Kristin Sippl
This is a quick and easy news article on the link between poverty, mercury pollution, and gold mining. It explains the problems in the jewelry industry as well as public and civil society attempts to address them. View Details
Sippl, Kristin. "From Blood Diamonds to Dirty Gold: How to Buy Gold Less Tainted by Mercury." The Conversation (December 22, 2015).
- March 2015
- Case
Bloodbuy
By: Richard G. Hamermesh and Michael Norris
In 2015, Chris Godfrey, founder and CEO of Bloodbuy, has to consider the best path to growth for his young company, which is attempting to disrupt the blood donation industry. View Details
Keywords: Health Care; Health Care Entrepreneurship; Blood Donation; Health Care and Treatment; Entrepreneurship; Health Industry; United States
Hamermesh, Richard G., and Michael Norris. "Bloodbuy." Harvard Business School Case 815-114, March 2015.
- June 2022
- Teaching Plan
Lifebank Nigeria
By: Brian Trelstad, Pippa Tubman Armerding and Wale Lawal
The aspiration of addressing maternal deaths in Nigeria, which were mostly caused by blood shortages, led Temie Giwa-Tubosun to found LifeBank in 2015. LifeBank developed an online platform that enabled hospitals to connect and purchase blood from local blood banks and... View Details
- October 2016 (Revised November 2016)
- Case
Innovating Beyond Ochsner
By: Richard G. Hamermesh and Olivia Hull
The Ochsner Health System has developed a proprietary software tool designed to treat hypertension. Built into the system’s electronic medical records, the Hypertension Digital Medicine program allows patients to record their blood pressure at home and share readings... View Details
Keywords: Electronic Medical Records; Telemedicine; Hypertension; High Blood Pressure; Chronic Disease; Entrepreneurship; Health Disorders; Business Model; Business Startups; Innovation and Invention; Growth Management; Marketing Strategy; Product Launch; Product Positioning; Science-Based Business; Business Strategy; Health Industry; Technology Industry; New Orleans; Louisiana
Hamermesh, Richard G., and Olivia Hull. "Innovating Beyond Ochsner." Harvard Business School Case 817-028, October 2016. (Revised November 2016.)
- October 2020
- Case
LifeBank Nigeria
By: Brian Trelstad, Pippa Tubman Armerding and Wale Lawal
The aspiration of addressing maternal deaths in Nigeria, which were mostly caused by blood shortages, led Temie Giwa-Tubosun to found LifeBank in 2015. LifeBank developed an online platform that enabled hospitals to connect and purchase blood from local blood banks and... View Details
Keywords: Systems Design; Social Business; Business At The Base Of The Pyramid; Health Care; Blood; Social Enterprise; Health Care and Treatment; Growth and Development Strategy; Finance; Health Industry; Transportation Industry; Africa; Nigeria
Trelstad, Brian, Pippa Tubman Armerding, and Wale Lawal. "LifeBank Nigeria." Harvard Business School Case 321-082, October 2020.
- February 2019 (Revised September 2019)
- Case
Theranos: The Unicorn That Wasn't
By: Joseph B. Fuller and John Masko
In 2003, 19-year-old Elizabeth Holmes founded a startup dedicated to making blood testing easier and more affordable. By 2015, her company, Theranos, was worth $9 billion. It boasted a star-studded board and contracts with national pharmacy and supermarket chains... View Details
Keywords: Theranos; Blood; Lab Testing; Fraud; Holmes; Balwani; Shultz; Carreyrou; Securities And Exchange Commission; Food And Drug Administration; FDA; SEC; Health Testing and Trials; Corporate Accountability; Organizational Culture; Misleading and Fraudulent Advertising; Crime and Corruption; Entrepreneurship; Medical Devices and Supplies Industry
Fuller, Joseph B., and John Masko. "Theranos: The Unicorn That Wasn't." Harvard Business School Case 319-068, February 2019. (Revised September 2019.)
- Article
The Multidimensional Effects of a Small Gift:: Evidence from a Natural Field Experiment
By: Ellen Garbarino, Robert Slonim and Carmen Wang
Using a large natural field experiment, we demonstrate that a small unconditional gift (pen) more than doubled both small (survey) and large (blood donation) responses. We find no evidence that the opportunity for a small response crowded out the larger response;... View Details
Keywords: Reciprocity; Gift Exchange; Blood Donation; Charitable Behavior; Field Experiment; Behavior; Philanthropy and Charitable Giving
Garbarino, Ellen, Robert Slonim, and Carmen Wang. "The Multidimensional Effects of a Small Gift: Evidence from a Natural Field Experiment." Economics Letters 120, no. 1 (July 2013): 83–61.
- December 2011
- Case
Bergerac Systems: The Challenge of Backward Integration
By: David A. Garvin and Sunru Yong
Bergerac Systems is a small, rapidly growing manufacturer of diagnostic instruments used in veterinary practices. The company introduced the OmniVue chemistry analyzer, which enables veterinarians to run a wide range of blood and blood chemistry tests on their animal... View Details
Keywords: Financial Analysis; Manufacturing Strategy; Strategy; Production; Supply Chain Management; Vertical Integration; Performance Capacity; Financial Strategy; Medical Devices and Supplies Industry
Garvin, David A., and Sunru Yong. "Bergerac Systems: The Challenge of Backward Integration." Harvard Business School Brief Case 114-381, December 2011.
- September 2014
- Case
Radiometer, 2003
By: John R. Wells and Galen Danskin
In 2003, Radiometer was the world's leading supplier of blood gas analysis equipment and accessories for critical care patients. Based in Denmark, Radiometer sold through a combination of sales subsidiaries and distributors around the world, and generated sales of over... View Details
Keywords: Medical Devices; Medical Equipment ＆ Devices; Mergers ＆ Acquisitions; Strategic Analysis; Strategic Change; Family Business; Strategy; Medical Devices and Supplies Industry; Denmark; United States
Wells, John R., and Galen Danskin. "Radiometer, 2003." Harvard Business School Case 715-409, September 2014.
- Article
How to End the Plasma Shortage for Coronavirus Patients
Those who have recovered from the virus will donate more blood if given the right incentives. View Details
Keywords: COVID-19; Convalescent Plasma; Health Pandemics; Health Care and Treatment; Market Design; Strategy
Kominers, Scott Duke. "How to End the Plasma Shortage for Coronavirus Patients." Bloomberg Opinion (May 11, 2020).
- June 2014 (Revised September 2014)
- Case
Johnson & Johnson: The Promotion of Wellness
By: John A. Quelch and Carin-Isabel Knoop
To create the world's healthiest workforce, diversified health care giant Johnson & Johnson (J&J) mandated participation in its "Culture of Health" program globally, customized by location, culture, and specific health needs to offer prevention-focused education,... View Details
Keywords: Healthcare; Employee Motivation; Transformation; Ethics; Health; Human Resources; Leadership; Management; Personal Development and Career; Problems and Challenges; Strategy; Health Industry; Medical Devices and Supplies Industry; Pharmaceutical Industry; North and Central America; Middle East; Latin America; Europe; Asia
Quelch, John A., and Carin-Isabel Knoop. "Johnson & Johnson: The Promotion of Wellness." Harvard Business School Case 514-112, June 2014. (Revised September 2014.)
- 15 Apr 2020
- Video
Vena Vitals: Runner-up in the 2020 New Venture Competition Alumni Track
- 22 Apr 2016
- HBS Seminar
Dr. Milt McColl, MD, Gauss Surgical, CEO
- November 1978 (Revised October 1989)
- Case
Amicon Corp. (A)
Amicon holds a patent on a new process for the separation of blood plasma from whole blood. It has to decide whether to pursue a direct entry, joint venture, or licensing strategy. If it chooses licensing, there are many sub-issues to consider. View Details
Capon, Noel. "Amicon Corp. (A)." Harvard Business School Case 579-093, November 1978. (Revised October 1989.)
- 15 Apr 2019
- News
Why Anxious Customers Prefer Human Customer Service
- 2024
- Working Paper
Chimeric Antigen Receptor T-Cell Therapy—Living Drugs: Case Histories of Transformational Advances
By: Amar Bhidé and Srikant M. Datar
In 2017, the US Food and Drug Administration (FDA) approved an immunotherapeutic treatment, called CAR-T therapy, for two kinds of blood cancers—acute leukemia (ALL) and a lymphoma. We describe 1) how CAR-T works, 2) the foundational advances and discoveries, 3) the... View Details
Keywords: Immunotherapy; Health Care and Treatment; Innovation and Invention; Research and Development; Governing Rules, Regulations, and Reforms
Bhidé, Amar, and Srikant M. Datar. "Chimeric Antigen Receptor T-Cell Therapy—Living Drugs: Case Histories of Transformational Advances." Harvard Business School Working Paper, No. 21-035, August 2020. (Revised May 2024.)